Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-03-23
1982-09-07
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424317, A61U 3119, A61U 3152
Patent
active
043483976
ABSTRACT:
There is provided a method of enhancing the retention of dyphylline in the human system. Dyphylline is a known bronchodilator whose pharmacological utility has been considerably restricted by its short in vivo half life. The retention of dyphylline in the system has been enhanced by coadministration of probenecid. The utility of dyphylline in asthma therapy is therefore considerably enhanced.
REFERENCES:
Chem. Abst., Chem. Sub Index, A-Cg (vol.-91), Benzoic Acid-4-Dipropylomine Sulfonyl.
Chem. Abst., Chem. Sub Index, 9th Collective 2-Propenenitrile, Acetyl-Pyridine, boryl. p. 33153CS.
Jarboe Charles H.
May David C.
Behr Omri M.
Friedman Stanley J.
Research Corporation
LandOfFree
Probenecid-dyphylline therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Probenecid-dyphylline therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Probenecid-dyphylline therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1342170